Marketwatch Strides Pharma gets tentative nod from USFDA for pain relieving drug Admin December 4, 2019 Strides Pharma Global Pte Ltd, Singapore, has received tentative approval for Diclofenac Potassium Softgel Capsules, 25 mg from the United States Food & Drug Administration (USFDA), Strides Pharma Science said in a regulatory filing. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
